Genetic Testing (PGT)
Preimplantation Genetic Testing (PGT) helps identify embryos that have recognizable chromosomal abnormalities prior to transfer to the uterus. PGT can be used for patients of all ages who have unexplained fertility, severe male factor, advanced maternal age and several failed IVF cycles with poor quality embryos. This procedure benefits families who have a known history of certain genetic abnormalities.
DIRM now offers blastocyst biopsy with next-generation sequencing (NGS) to IVF patients. NGS is a new technique that tests embryos for aneuploidy, an abnormal number (not 2) of all 22 chromosomes + sex chromosomes (X or Y). Our highly-trained embryologists can remove or biopsy several cells from a day 5 embryo (blastocyst) for genetic testing.
A blastocyst is comprised of hundreds of cells that have differentiated into an inner cell mass (which will develop into the fetus) and the trophectoderm (which will develop into the placenta). During blastocyst biopsy, a small hole is made in the zona pellucida (the shell surrounding the embryo) and several cells are removed from the trophectoderm for testing. The unharmed biopsied blastocysts are then returned to the incubator.
DIRM is truly a place where dreams, through science, become reality.